Public health impact of adjuvanted RSVPreF3 vaccine in older adults: a modeling study in nine countries in Middle East and North Africa

Public health impact of adjuvanted RSVPreF3 vaccine in older adults: a modeling study in nine countries in Middle East and North Africa

Background The adjuvanted RSV prefusion F protein vaccine (adjuvanted RSVPreF3) can protect older adults against respiratory syncytial virus (RSV) infection and RSV-related lower respiratory tract disease (LRTD). We modeled the burden of RSV and the potential public health impact of RSV vaccination...

Full description

Saved in:
Bibliographic Details
Main Authors: Evelina Zimovetz, Abdullah M. Assiri, Sara Al Dallal, Desirée van Oorschot, Adriana Guzman-Holst, Jorge A. Gomez, Ru Han
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Expert Review of Vaccines
Subjects:
Adjuvanted RSVPreF3 vaccine
Markov model
Middle East and North Africa
public health impact
RSV
Online Access:https://www.tandfonline.com/doi/10.1080/14760584.2025.2539886
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/14760584.2025.2539886

Similar Items